Baxter International (BAX) Asset Writedowns and Impairment (2010 - 2025)
Baxter International (BAX) reported Asset Writedowns and Impairment of $290.0 million for Q4 2025, up 3525.0% year-over-year from $8.0 million in Q4 2024, and up 14400.0% quarter-over-quarter from $2.0 million in Q2 2025.
Baxter International (BAX) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends
Baxter International (BAX) has 8 years of Asset Writedowns and Impairment data on file, last reported at $290.0 million in Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $290.0 million, up 3525.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $292.0 million (down 45.93% YoY), and the FY2025 annual result was $27.0 million, down 46.0% from the prior year.
- Asset Writedowns and Impairment grew to $290.0 million in Q4 2025 per BAX's latest filing, from $2.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $290.0 million in Q4 2025 and troughed at -$332.0 million in Q3 2022.
- A 5-year average of $84.7 million and a median of $16.5 million in 2021 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment plunged 255.56% in 2023, then soared 3525.0% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $11.0 million in 2021, then slipped by 18.18% to $9.0 million in 2022, then sank by 255.56% to -$14.0 million in 2023, then jumped by 157.14% to $8.0 million in 2024, then soared by 3525.0% to $290.0 million in 2025.
- Business Quant data shows BAX's Asset Writedowns and Impairment at $290.0 million in Q4 2025, $2.0 million in Q2 2025, and $22.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 290.00 Mn |
| Dec 31, 2025 | 290.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 267.00 Mn |
| Sep 30, 2024 | 267.00 Mn |
| Jun 30, 2024 | 243.00 Mn |
| Jun 30, 2024 | 243.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | 267.00 Mn |
| Sep 30, 2023 | 267.00 Mn |
| Jun 30, 2023 | 243.00 Mn |
| Jun 30, 2023 | 243.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Dec 31, 2022 | 9.00 Mn |